4Y0I

GABA-aminotransferase inactivated by conformationally-restricted inactivator


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.662 Å
  • R-Value Free: 0.204 
  • R-Value Work: 0.172 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

GABA-aminotransferase inactivated by conformationally-restricted inactivator

Lee, H.V.Dustin, D.H.Wu, R.Emma, D.Sanishvili, R.Liu, D.Neil, K.Silverman, R.B.

To be published.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
4-aminobutyrate aminotransferase, mitochondrial
A, B, C, D
461Sus scrofaMutation(s): 0 
Gene Names: ABAT (GABAT)
EC: 2.6.1.19
Find proteins for P80147 (Sus scrofa)
Go to Gene View: ABAT
Go to UniProtKB:  P80147
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
GOL
Query on GOL

Download SDF File 
Download CCD File 
B, C
GLYCEROL
GLYCERIN; PROPANE-1,2,3-TRIOL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
 Ligand Interaction
FES
Query on FES

Download SDF File 
Download CCD File 
A, C
FE2/S2 (INORGANIC) CLUSTER
Fe2 S2
NIXDOXVAJZFRNF-UHFFFAOYSA-N
 Ligand Interaction
PSZ
Query on PSZ

Download SDF File 
Download CCD File 
A, B, C, D
4-[({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)AMINO]THIOPHENE-2-CARBOXYLIC ACID
C13 H15 N2 O7 P S
SUKBSASAEROGCJ-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.662 Å
  • R-Value Free: 0.204 
  • R-Value Work: 0.172 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 69.483α = 90.00
b = 226.755β = 108.79
c = 71.425γ = 90.00
Software Package:
Software NamePurpose
Cootmodel building
PHENIXrefinement
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Cancer InstituteUnited StatesACB-12002

Revision History 

  • Version 1.0: 2016-02-17
    Type: Initial release
  • Version 1.1: 2017-09-20
    Type: Author supporting evidence, Derived calculations, Refinement description